Christopher Y Park
机构: Flatiron Institute, Simons Foundation
每年引用次数
引用次数
引用: 3,023
H-指数: 21
I10-指数 : 24
出版物: 39
COMPUTATIONAL FUNCTIONAL GENOMICS FOR DIRECTING BIOLOGICAL DISCOVERIES
Christopher Young Park
Princeton, NJ : Princeton University
2014
PAPERCLIP Identifies MicroRNA Targets and a Role of CstF64/64tau in Promoting Non-canonical poly(A) Site Usage
Hun-Way Hwang , Christopher Y. Park , Hani Goodarzi , John J. Fak
Cell Reports 15 ( 2) 423 -435
46
2016
AGO CLIP reveals an activated network for acute regulation of brain glutamate homeostasis after ischemic stroke
Mariko Kobayashi , Corinne Benakis , Corey Anderson , Michael J Moore
bioRxiv 245928
2018
NOVA2-mediated RNA regulation is required for axonal pathfinding during development.
Yuhki Saito , Soledad Miranda-Rottmann , Matteo Ruggiu , Christopher Y Park
eLife 5
62
2016
FMRP has a cell-type-specific role in CA1 pyramidal neurons to regulate autism-related transcripts and circadian memory.
Kirsty Sawicka , Caryn R Hale , Christopher Y Park , John J Fak
eLife 8
22
2019
ZFP36 RNA-binding proteins restrain T cell activation and anti-viral immunity.
Michael J Moore , Nathalie E Blachere , John J Fak , Christopher Y Park
eLife 7
25
2018
Regulatory consequences of neuronal ELAV-like protein binding to coding and non-coding RNAs in human brain
Claudia Scheckel , Elodie Drapeau , Maria A Frias , Christopher Y Park
eLife 5
84
2016
Expression profiling of the adhesion G protein-coupled receptor GPR133 (ADGRD1) in glioma subtypes.
Joshua D Frenster , Michael Kader , Scott Kamen , James Sun
Neuro-oncology advances 2 ( 1)
3
2020
Shift in MSL1 alternative polyadenylation in response to DNA damage protects cancer cells from chemotherapeutic agent-induced apoptosis
Alexander K Kunisky , Vivian I Anyaeche , R Samuel Herron , Christopher Y Park
Cell reports 37 ( 2)
5
2021
Translational regulation of TFH cell differentiation and autoimmune pathogenesis
Preeyam S Patel , Sandra Pérez-Baos , Beth Walters , Margo Orlen
Science Advances 8 ( 25) eabo1782
1
2022
The expression profile and tumorigenic mechanisms of CD97 (ADGRE5) in glioblastoma render it a targetable vulnerability
Niklas Ravn-Boess , Nainita Roy , Takamitsu Hattori , Devin Bready
Cell reports 42 ( 11)
3
2023
Methods for Analyzing Genetic Data to Classify Multifactorial Traits Including Complex Medical Disorders
Jian Zhou , Christopher Y Park , Chandra Theesfeld , Robert B Darnell
2
2021
NOVA1 acts as an oncogenic RNA-binding protein to regulate cholesterol homeostasis in human glioblastoma cells
Yuhki Saito , Yanhong Yang , Misa Saito , Christopher Y Park
Proceedings of the National Academy of Sciences 121 ( 10) e2314695121 -e2314695121
2024
IMP: a multi-species functional genomics portal for integration, visualization and prediction of protein functions and networks
Aaron K Wong , Christopher Y Park , Casey S Greene , Lars A Bongo
Nucleic Acids Research 40 484 -490
126
2012
Functional Knowledge Transfer for High-accuracy Prediction of Under-studied Biological Processes
Christopher Y Park , Aaron K Wong , Casey S Greene , Jessica Rowland
PLoS Computational Biology 9 ( 3) e1002957
50
2013
Interactive Big Data Resource to Elucidate Human Immune Pathways and Diseases
Dmitriy Gorenshteyn , Elena Zaslavsky , Miguel Fribourg , Christopher Y Park
Immunity 43 ( 3) 605 -614
41
2015
(Reg) ulation of hematopoietic lineage fates
Gopalkrishna Sreejit , Christopher Y Park
Blood 143 ( 3) 188 -190
2024
Genome-wide landscape of RNA-binding protein target site dysregulation reveals a major impact on psychiatric disorder risk
Olga G. Troyanskaya , Robert B. Darnell , Chandra L. Theesfeld , Aaron K. Wong
Nature Genetics 53 ( 2) 166 -173
33
2021
Tissue-specific enhancer functional networks for associating distal regulatory regions to disease.
Olga G. Troyanskaya , Chandra L. Theesfeld , Aaron K. Wong , Jian Zhou
Cell systems 12 ( 4)
1
2021
An automated framework for efficiently designing deep convolutional neural networks in genomics
Olga G. Troyanskaya , Chandra L. Theesfeld , Zijun Zhang , Christopher Y. Park
Nature Machine Intelligence 3 ( 5) 392 -400
1
2021